Physician

Thomas Edward Trischman, MD

According to 2025 Medicare claims, Thomas Trischman, MD (NPI: 1275161259) practices dermatology in the Kahului-Wailuku, HI market, with the plurality of this provider's patient population coming from Maui, HI. This provider's primary affiliated billing organization is AMY REISENAUER MD LLC (NPI: 1922550987; TIN: 811348437) and primary practice location at 96753-6945. Trischman is affiliated with the Central Minnesota ACO, LLC (ACO ID: A2844) and Mayo Clinic Community ACO, LLC (ACO ID: A4617), participating under the MSSP model.

Trischman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 463 traditional Medicare patients, billed 2,390 HCPCS/CPT codes, and received $129,572 in Medicare payments. The top billing code was 17004 (Destruction of precancer skin growth, 15 or more growths). Part D data shows 622 prescription claims across 257 beneficiaries totaling $199,622 in drug costs, led by Otezla (Apremilast). Open Payments data shows 2 records totaling $146. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $3,003 to $199,622. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$65K$130K2022 Medicare payment: $1,317 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $129,572 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
20221919$1,317
2023N/RN/RN/R
20244632,390$129,572

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$100K$200K2020 Drug cost: $3,003 (USD; Tot_Drug_Cst)2021 Drug cost: $4,895 (USD; Tot_Drug_Cst)2022 Drug cost: $7,906 (USD; Tot_Drug_Cst)2023 Drug cost: $71,008 (USD; Tot_Drug_Cst)2024 Drug cost: $199,622 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20201443$3,003
20214588$4,895
2022118192$7,906
2023123271$71,008
2024257622$199,622

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17004Destruction of precancer skin growth, 15 or more growths100101$148
11102Biopsy of related skin growth, first growth166178$80
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more262279$77
17000Destruction of precancer skin growth, 1 growth219229$41
17003Destruction of precancer skin growth, 2-14 growths174997$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OtezlaApremilast16478$78,117
Dupixent PenDupilumab17492$66,714
Clobetasol PropionateClobetasol Propionate621,679$3,606
FluorouracilFluorouracil19740$2,018
TacrolimusTacrolimus17324$1,999

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$146Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Thomas Edward Trischman, MD?

Tedicare shows public-source Medicare data for Thomas Edward Trischman, MD (NPI 1275161259), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Thomas Edward Trischman, MD have ACO affiliation data?

Thomas Edward Trischman, MD is shown with ACO affiliation data for Central Minnesota ACO, LLC (MSSP, ACO ID A2844) and Mayo Clinic Community ACO, LLC (MSSP, ACO ID A4617).

What billing organization is linked to Thomas Edward Trischman, MD?

Thomas Edward Trischman, MD is linked to AMY REISENAUER MD LLC (billing NPI 1922550987) in the available physician profile data.

Does Thomas Edward Trischman, MD have Open Payments data?

Thomas Edward Trischman, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.